Camilla Frimor
How is second- and third-line treatment in Inflammatory Bowel Diseases used today, and is Therapeutic Drug Monitoring at least as effective, and potentially a more cost-efficient strategy when using these more expensive treatments?
Charlotte Nielsen Agergaard
Anaerobic bacteremia; Clinical presentation, treatment response and outcome.
Christian Huusmann Stampe Andersen
Diagnosis and outcome of patients with sepsis and disseminated intravascular coagulation (DIC) in the ICU.